AISeeking Alphaabout 3 hours ago
Space and AI Stocks Outshine Biotech in 2026
1 min read
Speculative capital is favoring AI and space stocks over biotech in 2026, leaving the iShares Nasdaq Biotechnology ETF (IBB) lagging the S&P 500 year-to-date. IBB faces key resistance at $170 with potential upside to $190 on a breakout, though momentum remains lackluster.
Level
Hype check
Tap to vote and see what everyone thinks.
